Helle Pedersen

University of Copenhagen — Denmark

Biochemistry, Genetics and Molecular Biology · Life Sciences

33h-index8.4kcitations113works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gut microbiota and health(35), Cervical Cancer and HPV Research(32), Pancreatic and Hepatic Oncology Research(26), Gastric Cancer Management and Outcomes(26), Molecular Biology Techniques and Applications(14)

Publications109 total

Large‐Scale Study Comparing Analytical and Diagnostic Quality of Three <scp>HPV</scp> Self‐Sampling Devices for At‐Home Cervical Cancer Screening
Apmis·2025Open Access
Evaluation of targeted next‐generation sequencing for detection of <scp>HPV</scp> genotypes and sublineages in cervical liquid‐based cytology <scp>SurePath</scp> samples from the Danish screening program
International Journal of Cancer·2025Open Access
A gut microbiome-kidney-heart axis predictive of future cardiovascular diseases.
2025Open Access
The Allplex HPV HR Detection assay fulfils international guideline requirements for primary cervical screening on SurePath samples and qualifies as a second-generation HPV comparator test
Journal of Clinical Virology·2025Open Access
Participation and relative cost of attendance by direct‐mail compared to opt‐in invitation strategy for <scp>HPV</scp> self‐sampling targeting cervical screening non‐attenders: A large‐scale, randomized, pragmatic study
International Journal of Cancer·2024· 7 citedOpen Access
Performance of BD Onclarity HPV assay on FLOQSwabs vaginal self-samples
Microbiology Spectrum·2024· 16 citedOpen Access
Cervical cancer screening activity in the Capital Region of Denmark before, during and after the COVID-19 pandemic
Preventive Medicine·2024· 5 citedOpen Access
A unidirectional mapping of ICD-8 to ICD-10 codes, for harmonized longitudinal analysis of diseases
European Journal of Epidemiology·2023· 15 citedOpen Access
An Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides Modifies the Fecal Microbiome and Metabolome in Infants with Cow’s Milk Protein Allergy
International Journal of Molecular Sciences·2023· 30 citedOpen Access
Performance of BD Onclarity HPV assay on FLOQSwabs vaginal self-samples
2023· 1 citedOpen Access
Author Correction: Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models
Nature Biotechnology·2023· 1 citedOpen Access
Microbially Produced Imidazole Propionate Is Associated With Heart Failure and Mortality
JACC Heart Failure·2023· 52 citedOpen Access
Figure S3. from Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study
2023Open Access
Figure S10. from Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study
2023Open Access
Figure S9. from Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study
2023Open Access
Figure S4. from Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study
2023Open Access
Figure S5. from Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study
2023Open Access
Figure S2. from Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study
2023Open Access
Figure S5. from Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study
2023Open Access
Data from Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Jesper Bonde(18), Torben Hansen(16), Søren Brunak(14), Tue H. Hansen(13), Valborg Guðmundsdóttir(12), Trine Nielsen(12), Ditte Møller Ejegod(12), Sofia K. Forslund(11), Henrik Vestergaard(11), Edi Prifti(9), Gwen Falony(9), Sara Vieira‐Silva(9), Oluf Pedersen(9), S. Dusko Ehrlich(8), Florence Levenez(7), Jeroen Raes(7), Rima Chakaroun(7), Luís Pedro Coelho(7), Christine Rouault(7), Pilar Galán(7)